Blood Cleatance and Tissue Distribution of Various Formulations of α-Tocopherol Injection after Intravenous Administration
スポンサーリンク
概要
- 論文の詳細を見る
The in vivo elimination and tissue distribution (2 h after administration) of various types of formulations of α-tocopherol as a model drug were examined in rats. An organic cosolvents formulation of α-tocopherol (α-tocopherol/EtOH/polyethylene glycol 400) was rapidly removed from the blood circulation, the ratio of the distributed α-tocopherol was 20% in the lungs, about 70% in the liver and about 10% in the spleen. The main reason for this was considered to be the appearance of droplets more than 10 μm in diameter in the blood. Elimination of the micelle formulation using Brij58 from the blood was the most rapid, followed by Tween80 and HCO60. This order is thought to be due to the difference in the polyoxyethylene group among these surfactants.In liposome formulations, liposomes having a diameter of about 80 nm were the most stable in the blood circulation, and α-tocopherol was distributed in the reticuloendothelial system (RES) in the smallest ratio. The uptake of liposomes by the spleen and lungs depended on the liposome size. The uptaka by the liver was in the decreasing order of 28 nm ≫ 42nm, 151 nm, 195 nm, 3656 nm > 106 nm > 75 nm.The 100 nm lipid emulsion was eliminated form the blood more rapidly than the 100 nm liposome formulation.
- 社団法人日本薬学会の論文
- 1993-03-15
著者
-
渡辺 恭子
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
加藤 泰己
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.,
-
細川 俊仁
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.,
-
早川 栄治
Pharmaceutical Research Laboratories, Kyowa Kakko Kogyo Co., Ltd.,
-
伊藤 邦雄
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.,
-
中倉 政司
Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd.,
-
伊藤 邦雄
協和醗酵工業株式会社医薬総合研究所製剤研究所
-
早川 栄治
協和発酵工業株式会社医薬研究所
-
伊藤 邦雄
Pharmaceutical Institute Tohoku University
-
早川 栄治
協和醗酵工業株式会社医薬総合研究所製剤研究所
-
早川 栄治
協和発酵工業株式会社
-
加藤 泰己
協和醗酵工業株式会社医薬総合研究所製剤研究所
-
中倉 政司
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
-
細川 俊仁
Pharmaceutical Research Laboratories Kyowa Hakko Kogyo Co. Ltd.
関連論文
- Modification of Liposomes by Addition of HCO60. I. Targeting of Liposomes to Liver by Addition of HCO60 to Liposomes
- Blood Cleatance and Tissue Distribution of Various Formulations of α-Tocopherol Injection after Intravenous Administration
- Studies on Heart. XXIII. Distribution of [1-^C] Acetamidino-antiarrhythmic Peptide (^C-AAP) in Mice
- 1-Deoxy (2,4-dinitrophenyl) osazones as Characterizing Derivative of 3-Ketoses
- 新規な割線入りフィルムコーティング錠の分割性評価
- 12-4-F2 分割可能な新規フィルムコーティング錠の評価
- 12-4-F1 分割可能な新規フィルムコーティング錠の設計
- N^2-アセチル-L-グルタミンアルミニウム錯体の物理化学的性質コンドロイチン硫酸との相互作用
- Synthesis of Cyperene, Cyperotundone, and Patchoulenone
- Stereostructure of Rhodojaponin I, II, and III, Toxins of Rhododendron japonicum, and of Asebotoxin III, Toxin of Pieris japonica
- Stereostructure of Asebotoxin IV and V, Toxins of Pieris japonica
- 物性研究と製剤開発
- 分析における汚染と対策;医薬品
- イオントフォレシスによる経皮吸収に及ぼす薬物の脂溶性および極性表面積の影響
- Modification of Liposomes by Addition of HCO60. II. Encapsulation of Doxorubicin into Liposomes Containing HCO60
- Influence of Liposomes on Tryptic Digestion of Insulin. II
- Influence of Liposomes on Tryptic Digestion of Insulin
- Encapsulation of Doxorubicin into Liposomes by a Freeze-Thawing Method Using Buffer Solution
- 医薬と高分子
- Viscosity Study on the Self-Association of Doxorubicin in Aqueous Solution
- Visible Absorption and Proton Nuclear Magnetic Resonance Studies on the Self-Association of Doxorubicin in Aqueous Solution
- Studies on the Dissolution Behavior of Doxorubicin Hydrochloride Freeze-Dried Product
- 割線錠の分割性改善
- Stereostructure of Asebotoxin I and II, Toxins of Pieris japonica
- Structure of Pogostol